SmartTarget
Overview
SmartTarget is an AI-powered image fusion software developed by SmartTarget Ltd, a spin-out company of University College London (UCL). It is designed to enhance the accuracy of prostate cancer diagnosis and treatment by guiding targeted biopsies and minimally-invasive therapies. The software fuses diagnostic information from magnetic resonance imaging (MRI) with real-time transrectal ultrasound (TRUS) images, creating a 3D model of the prostate and identifying malignancies. This allows clinicians to precisely target areas of concern during procedures. The system features a clinician-designed, intuitive user interface and is agnostic to specific MR and ultrasound equipment. Its core technology utilizes machine learning techniques to assure accurate deformation and compensate for changes in prostate shape and position between images. The technology and related assets of SmartTarget were acquired by Miami-based Intuitive Fusion LLC in January 2020 for inclusion in its Focalyx Fusion product.
Note:The provided prompt indicated this tool is for a ‘physician directory’. This JSON reflects the actual product’s functionality.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- MRI-Ultrasound image fusion for prostate targeting
- 3D reconstruction of transrectal ultrasound (TRUS) images
- Real-time surgical guidance during biopsy and treatment
- Precision targeting for prostate biopsy procedures
- Supports minimally-invasive prostate cancer treatments (e.g., focal therapy)
- Clinician-designed, intuitive user interface
- Agnostic to specific MR and ultrasound equipment
- Machine learning for accurate deformation of MR models
- 2D and 3D image visualization features (review, multi-planar views, annotation)
- Automated compensation for changes in prostate shape and position
Use Cases
- Targeted prostate biopsy for cancer detection
- Image-guided interventional procedures involving the prostate gland
- Minimally-invasive prostate cancer treatments (focal therapy)
- Enhanced visualization during prostate diagnostic and treatment procedures
- Computer-assisted surgical planning for prostate cancer
- Improving detection rates of clinically significant prostate cancer
What Physicians Need to Know
Focalyx Fusion offers a precise, minimally invasive approach to prostate cancer management, allowing for targeted diagnosis, biopsy, and treatment while aiming to preserve patient quality of life. Consider its utility for appropriately selected low-risk and favorable-intermediate prostate cancer patients. The system's deformable fusion model and real-time guidance can enhance targeting accuracy. Be aware of the Windows 10 compatibility recall and ensure the system is validated for your operating environment. The integrated patient app can facilitate follow-up and communication.
Focalyx Fusion is designed for seamless integration into existing urology practice workflows and is compatible with various ultrasound manufacturers and positioning systems. It is also energy-agnostic, supporting different ablative modalities like cryoablation, HIFU, and IRE.
Details
| Category | Oncology AI, Radiology & Imaging AI, Surgical AI |
| Pricing | Contact for pricing |
| Deployment | On-premise (PC-based software) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Interventional Radiology, Radiology, Urology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2017-06-07 | K170250 510(k) | SmartTarget |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate SmartTarget
Videos
Product demos, reviews, and walkthroughs for SmartTarget.





